Case-Specific Results in Benzene (Blood Cancer) and Mesothelioma Cases [Slides for Download]

At our recent conference Genomic Analysis in Tort Cases, Kirk Hartley, Esq. chaired the first panel addressing the use of genomics in product liability and/or premises cases involving exposures to toxicants, including asbestos, benzene and radiation. Individual panelists provided summaries of cases they worked on involving genomics. Specifically, Kirk Hartley discussed the results from genetic sequencing in mesothelioma cases (including the results of three cases involving whole genome sequencing), while Howard Jarvis provided case specific results in benzene (blood cancer) and mesothelioma cases and the importance of sequencing germline DNA to help rule out the alleged causative agent and susceptibility to that agent. Larry Chilton built upon Howard Jarvis’ talk by discussing germline mutations in MDS/AML predisposition disorders, while Mark Zellmer discussed various factors that make up a good case for genetics work up.

The slides from this panel can be downloaded by completing the form below. The slides contain material from Kirk Hartley’s opening remarks, plus all slides from the Case-Specific Results in Benzene (Blood Cancer) and Mesothelioma Cases panelists, which included Kirk Hartley, Esq., Howard Jarvis, Esq., Larry Chilton, Esq., and Mark Zellmer, Esq.

DOWNLOAD NOW

Case-Specific Results in Benzene (Blood Cancer) and Mesothelioma Cases

  • This field is for validation purposes and should be left unchanged.